LeMaitre Vascular Management
Management criteria checks 4/4
LeMaitre Vascular's CEO is George LeMaitre, appointed in Jun 1992, has a tenure of 32.5 years. total yearly compensation is $2.22M, comprised of 26.7% salary and 73.3% bonuses, including company stock and options. directly owns 8.34% of the company’s shares, worth $173.80M. The average tenure of the management team and the board of directors is 14.7 years and 19.1 years respectively.
Key information
George LeMaitre
Chief executive officer
US$2.2m
Total compensation
| CEO salary percentage | 26.7% |
| CEO tenure | 32.5yrs |
| CEO ownership | 8.3% |
| Management average tenure | 14.7yrs |
| Board average tenure | 19.1yrs |
Recent management updates
Recent updates
LeMaitre Vascular (NASDAQ:LMAT) Has More To Do To Multiply In Value Going Forward
Dec 22
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) 26% Price Boost Is Out Of Tune With Earnings
Nov 24LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Nov 03LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Nov 02Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?
Oct 08Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$41m |
| Jun 30 2024 | n/a | n/a | US$38m |
| Mar 31 2024 | n/a | n/a | US$34m |
| Dec 31 2023 | US$2m | US$593k | US$30m |
| Sep 30 2023 | n/a | n/a | US$27m |
| Jun 30 2023 | n/a | n/a | US$25m |
| Mar 31 2023 | n/a | n/a | US$21m |
| Dec 31 2022 | US$2m | US$568k | US$21m |
| Sep 30 2022 | n/a | n/a | US$21m |
| Jun 30 2022 | n/a | n/a | US$22m |
| Mar 31 2022 | n/a | n/a | US$27m |
| Dec 31 2021 | US$2m | US$473k | US$27m |
| Sep 30 2021 | n/a | n/a | US$28m |
| Jun 30 2021 | n/a | n/a | US$29m |
| Mar 31 2021 | n/a | n/a | US$24m |
| Dec 31 2020 | US$1m | US$311k | US$21m |
| Sep 30 2020 | n/a | n/a | US$19m |
| Jun 30 2020 | n/a | n/a | US$16m |
| Mar 31 2020 | n/a | n/a | US$18m |
| Dec 31 2019 | US$1m | US$438k | US$18m |
| Sep 30 2019 | n/a | n/a | US$19m |
| Jun 30 2019 | n/a | n/a | US$18m |
| Mar 31 2019 | n/a | n/a | US$23m |
| Dec 31 2018 | US$1m | US$438k | US$23m |
| Sep 30 2018 | n/a | n/a | US$21m |
| Jun 30 2018 | n/a | n/a | US$22m |
| Mar 31 2018 | n/a | n/a | US$18m |
| Dec 31 2017 | US$889k | US$162k | US$17m |
Compensation vs Market: George's total compensation ($USD2.22M) is below average for companies of similar size in the US market ($USD5.51M).
Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.
CEO
George LeMaitre (59 yo)
32.5yrs
Tenure
US$2,220,797
Compensation
Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 32.5yrs | US$2.22m | 8.34% $ 173.8m | |
| President & Director | 17.4yrs | US$1.13m | 0.065% $ 1.4m | |
| CFO, Secretary & Director | 17.4yrs | US$1.07m | 0.041% $ 855.2k | |
| Senior Vice President of Operations | 19.9yrs | US$670.38k | 0.0086% $ 178.1k | |
| Founder and Chairman of Scientific Advisory Board | 41.9yrs | US$138.40k | no data | |
| Vice President of Marketing | 21.9yrs | no data | no data | |
| Senior Director of Human Resources | 4.9yrs | no data | no data | |
| Senior Vice President of Information Technology | less than a year | no data | no data | |
| Senior Vice President of Sales – Central Europe | less than a year | no data | no data | |
| Senior Vice President of Advanced Manufacturing Engineering | 1.9yrs | no data | no data | |
| Senior Vice President of Clinical | 11.9yrs | no data | no data | |
| Senior Vice President of EMEA Operations | 4.2yrs | no data | no data |
14.7yrs
Average Tenure
50.5yo
Average Age
Experienced Management: LMAT's management team is seasoned and experienced (14.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 32.5yrs | US$2.22m | 8.34% $ 173.8m | |
| President & Director | 23.6yrs | US$1.13m | 0.065% $ 1.4m | |
| CFO, Secretary & Director | 8.2yrs | US$1.07m | 0.041% $ 855.2k | |
| Founder and Chairman of Scientific Advisory Board | no data | US$138.40k | no data | |
| Independent Director | 21.9yrs | US$153.50k | 0.019% $ 406.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 16.3yrs | US$163.00k | 0.25% $ 5.2m | |
| Independent Director | 4.7yrs | US$144.50k | 0.0078% $ 162.2k |
19.1yrs
Average Tenure
60yo
Average Age
Experienced Board: LMAT's board of directors are seasoned and experienced ( 19.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 02:37 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LeMaitre Vascular, Inc. is covered by 22 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Raymond Myers | Benchmark Company |
| Jan Wald | Benchmark Company |